Key Takeaways
- • Private equity-backed healthcare companies are increasingly using joint ventures with nonprofit health systems as an expansion strategy, with at least 568 healthcare facilities now operating through such partnerships, according to a new report from the Private Equity Stakeholder Project (PESP).
- • Nonprofit-PE joint ventures span hospitals, rehabilitation facilities, ambulatory surgery centers, hospice, home health, and behavioral health sectors, representing a material shift in how private equity penetrates healthcare markets beyond traditional acquisitions.
- • These partnership structures allow PE-backed companies to expand into new markets, access established referral networks and patient populations, and share financial risk with nonprofit partners while potentially operating under different regulatory frameworks than outright acquisitions.
- • The PESP research indicates that nonprofit joint ventures have received substantially less public and regulatory scrutiny than traditional private equity buyouts despite their growing prevalence across the healthcare sector.
- • The emergence of this business model raises questions about whether existing federal and state oversight frameworks are adequately equipped to monitor and regulate these increasingly complex healthcare partnership structures.
Summary
The Private Equity Stakeholder Project has published research documenting a significant shift in private equity's healthcare expansion strategy: the proliferation of joint ventures between PE-backed healthcare companies and nonprofit health systems. According to PESP's findings, at least 568 healthcare facilities now operate through nonprofit-private equity joint ventures, marking a structural evolution in how alternative investors access and control healthcare assets across multiple subsectors.
Jim Baker, executive director of PESP, framed the strategic importance of these arrangements, stating that "private equity's healthcare playbook is evolving" and that PE firms have "increasingly relied on joint ventures with nonprofits to expand its presence in healthcare." The report emphasizes that this business model has generated far less public attention and regulatory scrutiny than traditional private equity acquisitions, despite becoming a dominant expansion mechanism across hospitals and other healthcare delivery platforms.
The appeal of nonprofit-PE joint ventures stems from several structural advantages. These partnerships enable PE-backed healthcare operators to enter new geographic markets and gain immediate access to established patient referral networks and existing customer bases. Additionally, the joint venture format allows financial risk to be distributed between PE sponsors and nonprofit partners, potentially making expansions more capital-efficient than outright acquisitions. Notably, these structures may also encounter different regulatory treatment under federal and state frameworks compared to conventional PE buyouts, a distinction that appears to have influenced their adoption rate.
The research raises a critical governance question: whether federal and state regulatory oversight mechanisms have evolved sufficiently to adequately monitor and control these increasingly complex healthcare partnerships. The volume of facilities now operating under nonprofit-PE joint venture structures—spanning acute care hospitals, rehabilitation services, ambulatory surgery centers, hospice operations, home health agencies, and behavioral health platforms—suggests the strategy has become material to PE portfolio expansion strategies. The limited transparency surrounding these arrangements relative to traditional PE acquisitions underscores potential gaps in existing oversight frameworks designed when PE healthcare strategies were primarily acquisition-focused.
Jim Baker, executive director of PESP, framed the strategic importance of these arrangements, stating that "private equity's healthcare playbook is evolving" and that PE firms have "increasingly relied on joint ventures with nonprofits to expand its presence in healthcare." The report emphasizes that this business model has generated far less public attention and regulatory scrutiny than traditional private equity acquisitions, despite becoming a dominant expansion mechanism across hospitals and other healthcare delivery platforms.
The appeal of nonprofit-PE joint ventures stems from several structural advantages. These partnerships enable PE-backed healthcare operators to enter new geographic markets and gain immediate access to established patient referral networks and existing customer bases. Additionally, the joint venture format allows financial risk to be distributed between PE sponsors and nonprofit partners, potentially making expansions more capital-efficient than outright acquisitions. Notably, these structures may also encounter different regulatory treatment under federal and state frameworks compared to conventional PE buyouts, a distinction that appears to have influenced their adoption rate.
The research raises a critical governance question: whether federal and state regulatory oversight mechanisms have evolved sufficiently to adequately monitor and control these increasingly complex healthcare partnerships. The volume of facilities now operating under nonprofit-PE joint venture structures—spanning acute care hospitals, rehabilitation services, ambulatory surgery centers, hospice operations, home health agencies, and behavioral health platforms—suggests the strategy has become material to PE portfolio expansion strategies. The limited transparency surrounding these arrangements relative to traditional PE acquisitions underscores potential gaps in existing oversight frameworks designed when PE healthcare strategies were primarily acquisition-focused.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.